GSE124703
CRISPR-based multimodal genetic screens in human iPSC-derived neurons
CRISPR/Cas9-based functional genomics have transformed our ability to elucidate mammalian cell biology. Most previous CRISPR-based screens were implemented in cancer cell lines, rather than healthy, differentiated cells. Here, we describe a CRISPR interference (CRISPRi)-based platform for genetic screens in human neurons derived from induced pluripotent stem cells (iPSCs). We demonstrate robust and durable knockdown of endogenous genes in such neurons, and present results from three complementary genetic screens. A survival-based screen revealed neuron-specific essential genes and a small number of genes that improved neuronal survival upon knockdown. A screen with a single-cell transcriptomic readout uncovered several examples for genes knockdown of which had dramatically different cell-type specific consequences. A longitudinal imaging screen detected distinct consequences of gene knockdown on neuronal morphology. Our results highlight the potential of interrogating cell biology in iPSC-derived differentiated cell types and provide a platform for the systematic dissection of normal and disease states of neurons. Overall design: The Quant-seq experiments were performed using iPSC-derived neurons at Day 14, Day 21 and Day 28 of differentiation with 2 replicates for each sample. The CROP-seq experiments were performed using iPSCs and Day 7 neurons infected by a library of sgRNAs. Two lanes of 10X platform were used for each CROP-seq sample.